Consensus-based Statement 6.S43 | |
---|---|
Expert consensus | Strength of consensus +++ |
The risk of ovarian insufficiency following the administration of tyrosine kinase inhibitors (TKI) is unclear, with TKI reported to have a teratogenic potential. |
Consensus-based Statement 6.S43 | |
---|---|
Expert consensus | Strength of consensus +++ |
The risk of ovarian insufficiency following the administration of tyrosine kinase inhibitors (TKI) is unclear, with TKI reported to have a teratogenic potential. |